ARCHIVES

DCT Board Approves Drug Development Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

November 5, 1999

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

The President’s Cancer Panel publishes its annual report

May 6, 2011